Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sarah, Dombos"'
Autor:
Norman Huang, Iuliia Weber, Hans-Ulrich Pfeiffer, Erhard Seifried, Reinhard Henschler, Michael Schmidt, Anna Erickson, Johannes Leibacher, Laurence Corash, Christine Ernst, Richard J. Benjamin, Katharina Madlener, Sarah Dombos, Markus Müller, Nina Mufti, Veronika Brixner, AH Kiessling, Anne North, Salvador Rico, Christof Geisen
Publikováno v:
Transfusion. 58:905-916
Background Nucleic acid-targeted pathogen inactivation technology using amustaline (S-303) and glutathione (GSH) was developed to reduce the risk of transfusion-transmitted infectious disease and transfusion-associated graft-versus-host disease with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb04c97d740d6ef4faed53a290fc9e71
https://doi.org/10.1111/trf.14528
https://doi.org/10.1111/trf.14528
Autor:
Veronika, Brixner, Arndt-Holger, Kiessling, Katharina, Madlener, Markus M, Müller, Johannes, Leibacher, Sarah, Dombos, Iuliia, Weber, Hans-Ulrich, Pfeiffer, Christof, Geisen, Michael, Schmidt, Reinhard, Henschler, Anne, North, Norman, Huang, Nina, Mufti, Anna, Erickson, Christine, Ernst, Salvador, Rico, Richard J, Benjamin, Laurence M, Corash, Erhard, Seifried
Publikováno v:
Transfusion. 58(4)
Nucleic acid-targeted pathogen inactivation technology using amustaline (S-303) and glutathione (GSH) was developed to reduce the risk of transfusion-transmitted infectious disease and transfusion-associated graft-versus-host disease with red blood c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::485e0e2bbac5d9a34510dd37116dd01d
https://pubmed.ncbi.nlm.nih.gov/29498049
https://pubmed.ncbi.nlm.nih.gov/29498049